利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

129 条记录 (耗时 0.04 秒)

    Method to remotely provide television broadcast recording services to broadcast television service subscribers
    72.
    发明授权
    Method to remotely provide television broadcast recording services to broadcast television service subscribers 有权
    向广播电视服务用户远程提供电视广播录制服务的方法

    公开(公告)号：US07526787B1

    公开(公告)日：2009-04-28

    申请号：US12163174

    申请日：2008-06-27

    申请人： Robert Vernon Williamson ,  Michael Reed ,  Linda Jones Scott

    发明人： Robert Vernon Williamson ,  Michael Reed ,  Linda Jones Scott

    IPC分类号： G06F3/00 ,  H04N7/173 ,  H04N5/91

    CPC分类号： H04N5/76 ,  H04N5/765 ,  H04N21/24 ,  H04N21/2747 ,  H04N21/47214 ,  H04N21/6332

    摘要： A system and method for remotely recording television programs using a remote redundant recording system in case of local DVR system failure. The system and method enables a subscriber station to transmit a plurality of recorded timers to a television provider's head end where the timers are associated with television programs the subscriber desires to have remotely recording in case of a local DVR failure. This system and method also enables the data processor at the television provider's head end to monitor the digital recording device while the programs selected are being broadcast, and in the event of a power outage, record the program selected on the data storage space.

    摘要翻译： 在本地DVR系统故障的情况下，使用远程冗余记录系统远程录制电视节目的系统和方法。 该系统和方法使得订户台能够向电视提供商的头端发送多个记录的定时器，其中定时器与用户希望在本地DVR故障的情况下具有远程记录的电视节目相关联。 该系统和方法还使得电视提供商的头端的数据处理器在所选择的节目正在广播的同时监视数字记录装置，并且在停电的情况下，记录在数据存储空间上选择的节目。

    Process for the synthesis of pyrazolopyrimidines
    73.
    发明申请
    Process for the synthesis of pyrazolopyrimidines 审中-公开
    合成吡唑并嘧啶的方法

    公开(公告)号：US20070060744A1

    公开(公告)日：2007-03-15

    申请号：US11448218

    申请日：2006-06-06

    申请人： Robert Dempcy ,  A. Adams ,  Michael Reed ,  Yevgeniy Belousov

    发明人： Robert Dempcy ,  A. Adams ,  Michael Reed ,  Yevgeniy Belousov

    IPC分类号： C07H19/04

    CPC分类号： C07H19/04 ,  C07H19/044

    摘要： The present invention provides a nucleoside comprising a pyrazolopyrimidine base and a process for producing the same. In particular, the processes of the present invention comprises using a halogenated pyrazolopyrimidine base and removing the halogen after the base is coupled to a sugar moiety. The presence of the halogen on the nucleoside base allows facile and economical production of a large quantity of nucleosides.

    摘要翻译： 本发明提供了包含吡唑并嘧啶碱的核苷及其制备方法。 特别地，本发明的方法包括使用卤代吡唑并嘧啶碱，并且在碱偶联到糖部分后除去卤素。 在核苷碱基上存在卤素可以容易地和经济地生产大量的核苷。

    Nanoporous layers using thermal dealloying
    76.
    发明申请
    Nanoporous layers using thermal dealloying 审中-公开
    使用热脱金属的纳米多孔层

    公开(公告)号：US20060193889A1

    公开(公告)日：2006-08-31

    申请号：US11352427

    申请日：2006-02-10

    申请人： Joshua Spradlin ,  Whye-Kei Lye ,  Michael Reed ,  Matthew Hudson

    发明人： Joshua Spradlin ,  Whye-Kei Lye ,  Michael Reed ,  Matthew Hudson

    IPC分类号： A61H21/00 ,  A61F2/00

    CPC分类号： A61L31/022 ,  A61F2/07 ,  A61F2/91 ,  A61F2/915 ,  A61F2002/91541 ,  A61F2210/0076 ,  A61F2250/0067 ,  A61L31/10 ,  A61L31/146 ,  A61L31/16 ,  A61L31/18 ,  A61L2300/606 ,  A61L2400/12 ,  A61N1/05

    摘要： The present invention relates generally to medical devices with therapy eluting components and methods for making same. More specifically, the invention relates to implantable medical devices having at least one porous layer, and methods for making such devices, and loading such devices with therapeutic agents. A mixture or alloy is placed on the surface of a medical device, then one component of the mixture or alloy is generally removed without generally removing the other components of the mixture or alloy. In some embodiments, a porous layer is adapted for bonding non-metallic coating, including drug eluting polymeric coatings. A porous layer may have a random pore structure or an oriented or directional grain porous structure. One embodiment of the invention relates to medical devices, including vascular stents, having at least one porous layer adapted to resist stenosis or cellular proliferation without requiring elution of therapeutic agents. The invention also includes methods, devices, and specifications for loading of drugs and other therapeutic agents into nanoporous coatings.

    摘要翻译： 本发明一般涉及具有治疗洗脱组分的医疗装置及其制备方法。 更具体地，本发明涉及具有至少一个多孔层的可植入医疗装置，以及用于制造这种装置的方法，以及用治疗剂加载这些装置。 将混合物或合金放置在医疗装置的表面上，然后通常除去混合物或合金的一种组分，而不会通常除去混合物或合金的其它组分。 在一些实施例中，多孔层适于粘合非金属涂层，包括药物洗脱的聚合物涂层。 多孔层可以具有无规孔结构或定向或定向颗粒多孔结构。 本发明的一个实施方案涉及包括血管支架的医疗装置，其具有适于抵抗狭窄或细胞增殖的至少一个多孔层，而不需要洗脱治疗剂。 本发明还包括将药物和其它治疗剂装载到纳米多孔涂层中的方法，装置和规格。

    Methods for treating or preventing cancer by preventing, inhibiting, or arresting cell cycling
    79.
    发明申请
    Methods for treating or preventing cancer by preventing, inhibiting, or arresting cell cycling 失效
    通过预防，抑制或阻止细胞循环来治疗或预防癌症的方法

    公开(公告)号：US20060122161A1

    公开(公告)日：2006-06-08

    申请号：US11244416

    申请日：2005-10-05

    申请人： Michael Reed ,  Barry Potter

    发明人： Michael Reed ,  Barry Potter

    IPC分类号： A61K31/56 ,  A61K31/57

    CPC分类号： A61K31/566 ,  A61K31/352 ,  A61K31/565

    摘要： There is provided use of a cyclic compound or a pharmaceutically active salt thereof in the manufacture of a medicament to prevent and/or inhibit and/or arrest cell cycling, wherein the cyclic compound comprises at least one ring, wherein Group I and Group II, independently of each other, are attached to a ring of the cyclic compound; wherein Group I is a hydrocarbyl or an oxyhydrocarbyl group; and wherein Group II is a group of the formula X is P or S; when X is P, Y is ═O or S, Z is —OH and R is hydrocarbyl or H; when X is S, Y is ═O, Z is ═O, and R is hydrocarbyl or N(R1)(R2), wherein each of R1 and R2 is independently selected from H or a hydrocarbyl group.

    摘要翻译： 提供环状化合物或其药物活性盐在制备用于预防和/或抑制和/或阻止细胞循环的药物中的用途，其中所述环状化合物包含至少一个环，其中第I组和第II组， 彼此独立地连接到环状化合物的环上; 其中组I是烃基或氧代烃基; 并且其中II族是式X的基团是P或S; 当X为P时，Y为-O或S，Z为-OH，R为烃基或H; 当X为S时，Y为-O，Z为-O，R为烃基或N（R 1 H 2）（R 2），其中R > 1＆gt;和R 2 2独立地选自H或烃基。